LONG BEACH, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (Nasdaq: RKLB), a leading launch and space systems company, today announced that in partnership with Raytheon it has been ...

Holding clients accountable is a cornerstone of effective coaching, but getting this part right goes beyond simple check-ins and goal reminders. To truly show a client a return on their investment, ...

Groceries, transportation, dining out and gas make up the bulk of the monthly budget for most American households, and their costs are rising. The silver lining is that charging these expenses to the ...

NEW YORK, April 21 (Reuters) - Meta (META.O), opens new tab is installing new tracking software on U.S.-based employees’ computers to capture mouse movements, clicks and keystrokes for use in training ...

The Center for Transforming Lives headquarters in southeast Fort Worth on Monday, Oct. 13, 2025. The Center is taking over rental and utility assistance for Tarrant County. Center for Transforming ...

ROCK ISLAND, Ill. — The Rock Island City Council has approved a year-long pilot program to use Raven gunshot detection devices. The Raven devices are manufactured by surveillance company Flock, which ...

Jessica hails from Northern Ireland, and has written thousands of guides across sites such as Eurogamer, PCGamer, IGN, and PCGamesN. She also ventures into the lands of reviews, news, interviews, and ...

LONDON, April 6 (Reuters) - Amazon, Microsoft and Alphabet's Google have each recently abandoned construction of multibillion-dollar data centers over community opposition and now the companies are ...

Edwards Lifesciences (NYSE: EW) today announced new data on the EVOQUE transcatheter tricuspid valve replacement (TTVR) system at the American College of Cardiology Annual Scientific Session (ACC.26), ...

John Steinbach was shocked to receive a $281 electricity bill in January 2026—a huge spike from the roughly $100 he’d paid the previous month. “It’s just so far beyond any bill that I’ve ever had,” he ...

ZURICH--(BUSINESS WIRE)--AL-S Pharma AG, a clinical-stage biotechnology company discovering and developing human antibodies that target misfolded proteins implicated in amyotrophic lateral sclerosis ...

Preparations underway to advance AP-101 into confirmatory Phase 3 clinical trial with initiation aimed for late 2026 AL-S Pharma AG, a clinical-stage biotechnology company discovering and developing ...